Anti p53 antibody and suppressor reagents: reading the mutation without reading it wrongly

Reading these stains correctly

1. Know which direction the stain runs. For proteins stabilised by mutation, high signal indicates a likely mutation and low signal indicates either normal turnover or a truncating change. The stain is a pattern, and the pattern has to be interpreted rather than read as amount.
2. Treat absence as the hardest claim. A negative stain can mean loss, a failed reagent, poor fixation or an epitope that was removed by a truncation. An internal positive control within the same section, such as normal stroma, is what makes absence credible.
3. Use mutation specific reagents only for their exact change. A reagent raised against one substitution detects that substitution and usually not its neighbours. Reporting it as detecting mutant protein generally is an overstatement.
4. Confirm surrogates against sequence. Where a stain is used as a proxy for a genotype, its concordance with sequencing has to be established in your own material before it is relied on.
5. Separate lineage from driver. Several reagents in this group identify a cell of origin rather than a driver event. Using them to infer mechanism is a common and avoidable overreach.

Accumulation is the signal, not the function

The stain reports steady state protein, and steady state is set by synthesis and degradation. A change that blocks degradation raises the level of a protein that no longer works, which is why the intuitive reading is unreliable here more than anywhere else.

Describe the pattern in the methods and the interpretation in the discussion, rather than reporting intensity as if it were activity.

Internal controls make sections interpretable

Almost every tissue section contains cells that should be positive: stroma, immune infiltrate, adjacent normal epithelium. Using them as internal controls turns a stain into a comparison rather than an absolute.

Point them out in the figure. A reader can then judge for themselves whether a negative tumour was truly negative or the section simply did not stain.

A pten antibody and a loss that has to be proved

PTEN work is nearly always about absence, and absence is harder to demonstrate than presence: a pten antibody needs a positive control line on the same blot and an internal positive population in the same section, or a negative result is indistinguishable from a failed stain. Downstream phosphorylated AKT is the functional confirmation, and a knockout line is the validation worth paying for.

An mdm2 antibody and the partner it is read with

MDM2 degrades the page's own antigen, so the two are measured together and a rise in one with a fall in the other is the expected result. An mdm2 antibody has to state whether it sees the full length protein or the several smaller isoforms the gene produces, since a figure showing one band on a gene with many is usually reading only part of the story. Proteasome inhibition is the control that stabilises it.

An nf1 antibody and a very large tumour suppressor

Neurofibromin is one of the largest proteins commonly blotted, so an nf1 antibody fails on transfer far more often than on specificity: a low percentage gel, a long wet transfer and a positive control lysate are what produce a band. Loss is the usual question, so the same proof of absence applies as for any suppressor, and downstream RAS activity is the functional readout.

An rb antibody and the phosphorylation that switches it off

Retinoblastoma protein is inactivated by phosphorylation rather than by degradation, so an rb antibody for total protein shows little while a phospho clone against a named serine reports the state. The two forms run close together, which is why a phosphatase treated lane is sometimes the clearest evidence. A serum starved population is the hypophosphorylated control the comparison needs.

A p27 antibody and a level set by degradation

This inhibitor is regulated by proteolysis rather than by transcription, so a p27 antibody reports the output of a degradation pathway and a proteasome inhibitor lane is the control that shows it. Its location matters too, since the cytoplasmic protein has a different role from the nuclear one, and a fractionation or an image is what separates them. It is small and abundant enough to overload easily.

An mtap antibody and a deletion read as an absence

MTAP is co-deleted with a neighbouring suppressor in many tumours, which is exactly why it is measured, and again the readout is loss. An mtap antibody therefore needs a retained internal population, usually stroma in the same section, to show the stain worked where the tumour reads negative. Without that internal control a negative slide proves nothing about the deletion.

A brca2 antibody and the size that defeats most blots

BRCA2 is very large and expressed at low levels, which is the combination that makes a blot hard: transfer conditions decide whether anything appears, and a long exposure on a standard gel gives a smear rather than a band. A brca2 antibody is more often used for immunofluorescence foci after damage, where the readout is focus number per nucleus with a stated scoring rule.

A vhl antibody and two isoforms from one message

The gene produces a longer and a shorter protein from alternative translation starts, so a vhl antibody should show two bands and a datasheet claiming one is describing an incomplete picture. Loss of function is the disease, and the functional readout is stabilised hypoxia inducible factor under normal oxygen, which is the control that turns a missing band into a mechanism.

Common questions

Does strong staining mean the suppressor is working?

Often the opposite. Missense changes that abolish function also abolish the degradation that keeps the protein low, so accumulation is a marker of a likely mutation rather than of activity.

Can a stain replace sequencing?

For a few well characterised changes with validated reagents, it can be an effective screen. It is not equivalent, and the concordance has to be established locally before the stain is used in place of the sequence.

How do I make a negative anti p53 antibody stain credible?

With an internal positive control in the same section, a reagent whose epitope is unlikely to be lost by truncation, and where possible a second reagent against a different region.

Browse by service class

• Compare Gene synthesis on advertised prices